Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

0.91USD
3:25pm EDT
Change (% chg)

$0.03 (+3.35%)
Prev Close
$0.88
Open
$0.87
Day's High
$0.92
Day's Low
$0.85
Volume
45,238
Avg. Vol
95,019
52-wk High
$3.44
52-wk Low
$0.55

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 10.18 -0.121
Sep '18 19.52 0.159
Jun '18 6.87 -0.104
Mar '18 7.85 -0.146
FY 2017 Dec '17 20.64 0.220
Sep '17 5.11 -0.284
Jun '17 6.20 -0.405
Mar '17 6.21 -0.607
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 6.20 6.20 6.20 6.20
Quarter Ending Jun-19 1 6.20 6.20 6.20 6.20
Year Ending Dec-19 3 33.95 42.30 25.00 21.77
Year Ending Dec-20 3 26.68 35.23 20.00 23.56
Earnings (per share)
Quarter Ending Mar-19 1 -0.41 -0.41 -0.41 -0.48
Quarter Ending Jun-19 1 -0.40 -0.40 -0.40 -0.47
Year Ending Dec-19 3 -0.96 -0.41 -1.58 -1.12
Year Ending Dec-20 3 -0.95 -0.36 -1.29 -0.87
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 99.54 58.10
P/E High - Last 5 Yrs. -- 163.20 55.59
P/E Low - Last 5 Yrs. -- 52.29 28.94
Beta 1.78 1.07 0.93
Price to Sales (TTM) 0.77 46.98 8.84
Price to Book (MRQ) 0.71 11.92 4.60
Price to Tangible Book (MRQ) 0.71 17.18 7.88
Price to Cash Flow (TTM) -- 66.14 40.07
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.50
Dividend Yield - 5 Year Avg -- 0.05 1.35
Dividend 5 Year Growth Rate -- 0.83 -7.09
Payout Ratio(TTM) -- 9.40 41.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -50.66 25.03 25.74
Sales (TTM) vs TTM 1 Yr. Ago 16.43 53.42 6.96
Sales - 5 Yr. Growth Rate 3.29 32.93 11.63
EPS (MRQ) vs Qtr. 1 Yr. Ago -154.83 -103.90 97.20
EPS (TTM) vs TTM 1 Yr. Ago 80.34 -- --
EPS - 5 Yr. Growth Rate -- 21.44 7.76
Capital Spending - 5 Yr. Growth Rate 3.29 25.61 9.29

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.76 2.53
Current Ratio (MRQ) 5.04 3.59 3.46
LT Debt to Equity (MRQ) 0.00 7.33 13.97
Total Debt to Equity (MRQ) 0.00 20.18 17.66
Interest Coverage (TTM) -- 8.20 40.37

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 22.22 51.28
Gross Margin - 5 Yr. Avg. -- 60.85 51.25
EBITD Margin (TTM) -14.79 -- --
EBITD - 5 Yr. Avg -160.54 -9.95 16.00
Operating Margin (TTM) -22.61 -128.70 5.25
Operating Margin - 5 Yr. Avg. -167.79 -25.37 11.28
Pre-Tax Margin (TTM) -19.10 -127.93 4.73
Pre-Tax Margin - 5 Yr. Avg. -166.08 -28.19 16.33
Net Profit Margin (TTM) -18.24 -134.24 0.91
Net Profit Margin - 5 Yr. Avg. -165.59 -33.55 11.45
Effective Tax Rate (TTM) -- 19.93 22.81
Effective Tax Rate - 5 Yr. Avg. -- 19.78 23.76

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,019,136 8,285,183 743,211,585
Net Income/Employee (TTM) -368,227 2,627,911 86,142,407
Receivable Turnover (TTM) 25.89 2.34 4.94
Inventory Turnover (TTM) -- 2.32 3.73
Asset Turnover (TTM) 0.51 0.32 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -9.24 6.20 9.77
Return on Assets - 5 Yr. Avg. -28.94 6.09 10.84
Return on Investment (TTM) -23.27 7.80 12.12
Return on Investment - 5 Yr. Avg. -40.20 7.99 13.99
Return on Equity (TTM) -- 7.82 13.24
Return on Equity - 5 Yr. Avg. -313.55 9.11 15.41
  1 Year 3 Year 5 Year
Sales % 16.43 19.70 3.29
EPS (TTM) % 80.25 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoMed Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -1.46 83 24
13 Week 45.31 25.38 99 9
26 Week -61.92 -60.16 22 2
52 Week -69.11 -70.84 29 5
YTD 18.23 5.82 99 4
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 55.89%
# of Holders: 55
Total Shares Held: 21,623,667
3 Mo. Net Change: -3,432,195
# New Positions: 4
# Closed Positions: 20
# Increased Positions: 12
# Reduced Positions: 36
# Net Buyers: -24
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.